The FDArevised the emergency use authorization(EUA) for both Paxlovid and Lagevrio on Wednesday.
Fact sheets regarding the updated EUA note a removal of the requirement for SARS-CoV-2 viral testing.
What Is Lagevrio?
Basak Gurbuz Derman / Getty Images
Lagevrio (molnupiravir) is an antiviral drug from Merck used to treat COVID-19.
The reason why a test is no longer necessary is unclear.
Recommend, of course, is different than require.
Regardless of the EUA, best medical practice is to actually confirm COVID-19 before prescribing an antiviral.
Others believe the change eliminates an unnecessary barrier to getting people treatment when its clear theyre sick.
The change may also be hedging against a future lack of tests.
For the most recent updates on COVID-19, visit ourcoronavirus news page.
